APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,296,234 | +171.5% | 431,973 | +454.3% | 0.01% | +250.0% |
Q2 2023 | $7,107,630 | +36.1% | 77,926 | -22.8% | 0.00% | 0.0% |
Q4 2022 | $5,224,189 | -41.5% | 100,931 | -22.0% | 0.00% | -50.0% |
Q3 2022 | $8,924,000 | +14.3% | 129,339 | -23.1% | 0.00% | 0.0% |
Q2 2022 | $7,809,000 | -6.2% | 168,125 | +0.0% | 0.00% | 0.0% |
Q1 2022 | $8,325,000 | -5.1% | 168,107 | -6.4% | 0.00% | -20.0% |
Q4 2021 | $8,768,000 | +1.7% | 179,681 | -29.2% | 0.01% | +25.0% |
Q3 2021 | $8,618,000 | -47.1% | 253,728 | -0.3% | 0.00% | -50.0% |
Q2 2021 | $16,293,000 | +106.2% | 254,493 | +33.8% | 0.01% | +60.0% |
Q1 2021 | $7,901,000 | -11.9% | 190,145 | +19.3% | 0.01% | -16.7% |
Q4 2020 | $8,967,000 | -19.7% | 159,339 | -53.6% | 0.01% | -33.3% |
Q3 2020 | $11,172,000 | +5.1% | 343,320 | +2.5% | 0.01% | -10.0% |
Q2 2020 | $10,627,000 | +502.4% | 334,830 | +396.0% | 0.01% | +400.0% |
Q1 2020 | $1,764,000 | -55.8% | 67,500 | -48.2% | 0.00% | -33.3% |
Q4 2019 | $3,989,000 | +3810.8% | 130,268 | +2972.4% | 0.00% | – |
Q3 2019 | $102,000 | -1.0% | 4,240 | +4.7% | 0.00% | – |
Q2 2019 | $103,000 | +1371.4% | 4,048 | +696.9% | 0.00% | – |
Q4 2018 | $7,000 | +75.0% | 508 | +104.0% | 0.00% | – |
Q3 2018 | $4,000 | -33.3% | 249 | -2.7% | 0.00% | – |
Q2 2018 | $6,000 | – | 256 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |